Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Ling-ling Zhu,1 Zhi-jun Feng,2 Quan Zhou3 1Geriatric VIP Ward, Division of Nursing, 2Department of Urology Surgery, 3Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China We read with great i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhu LL, Feng ZJ, Zhou Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/6db82784acbc448ab65276f3af05e013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6db82784acbc448ab65276f3af05e013
record_format dspace
spelling oai:doaj.org-article:6db82784acbc448ab65276f3af05e0132021-12-02T00:48:33ZPersonalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia1178-1998https://doaj.org/article/6db82784acbc448ab65276f3af05e0132015-03-01T00:00:00Zhttps://www.dovepress.com/personalized-therapeutics-of-alpha1-blockers-innbsppatients-with-lower-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Ling-ling Zhu,1 Zhi-jun Feng,2 Quan Zhou3 1Geriatric VIP Ward, Division of Nursing, 2Department of Urology Surgery, 3Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China We read with great interest the multicenter, prospective, comparative cohort study by Zhang et al1 who suggested that patients with uncontrolled or untreated hypertension and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS) should be warned about a decrease in blood pressure on initiation of alfuzosin 10 mg therapy alone or concomitantly with antihypertensive medication. Here we discuss and share our perspectives on this issue. View original paper by Zhang and colleagues. Zhu LLFeng ZJZhou QDove Medical Pressarticlebenign prostatic hyperplasiaα1-blockerspersonalized therapeuticsGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 621-624 (2015)
institution DOAJ
collection DOAJ
language EN
topic benign prostatic hyperplasia
α1-blockers
personalized therapeutics
Geriatrics
RC952-954.6
spellingShingle benign prostatic hyperplasia
α1-blockers
personalized therapeutics
Geriatrics
RC952-954.6
Zhu LL
Feng ZJ
Zhou Q
Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
description Ling-ling Zhu,1 Zhi-jun Feng,2 Quan Zhou3 1Geriatric VIP Ward, Division of Nursing, 2Department of Urology Surgery, 3Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China We read with great interest the multicenter, prospective, comparative cohort study by Zhang et al1 who suggested that patients with uncontrolled or untreated hypertension and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH/LUTS) should be warned about a decrease in blood pressure on initiation of alfuzosin 10 mg therapy alone or concomitantly with antihypertensive medication. Here we discuss and share our perspectives on this issue. View original paper by Zhang and colleagues. 
format article
author Zhu LL
Feng ZJ
Zhou Q
author_facet Zhu LL
Feng ZJ
Zhou Q
author_sort Zhu LL
title Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
title_short Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
title_full Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
title_fullStr Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
title_full_unstemmed Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
title_sort personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/6db82784acbc448ab65276f3af05e013
work_keys_str_mv AT zhull personalizedtherapeuticsofalpha1blockersinnbsppatientswithlowerurinarytractsymptomssuggestiveofbenignprostatichyperplasia
AT fengzj personalizedtherapeuticsofalpha1blockersinnbsppatientswithlowerurinarytractsymptomssuggestiveofbenignprostatichyperplasia
AT zhouq personalizedtherapeuticsofalpha1blockersinnbsppatientswithlowerurinarytractsymptomssuggestiveofbenignprostatichyperplasia
_version_ 1718403445114798080